OOIR: Observatory of International Research

Papers

(The H4-Index of Hepatology International is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Gut microbiota alteration in hepatobiliary diseases: cause-and-effect relationship	203
Platelets in acute liver failure: an innocent bystander or instigator?	110
Prognosis prediction or treatment allocation?	87
Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective	81
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives	80
MAFLD: from a disease framework to patient care	66
Diagnosis and management of pediatric acute liver failure: consensus recommendations of the Indian Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ISPGHAN)	56
Reconsiderations for the liver donation from a living donor: addressing hepatic steatosis with weight loss preconditioning	54
Development of a transformer model for predicting the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation	53
Review of current and new drugs for the treatment of metabolic-associated fatty liver disease	52
Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry	47
Diversity of the nucleic acid forms of circulating HBV in chronically infected patients and its impact on viral cycle	46
Anlotinib in the treatment of advanced hepatocellular carcinoma: an open-label phase II study (ALTER-0802 study)	45
Dairy products intake and prevalence, incidence, and recovery of non-alcoholic fatty liver disease in Chinese population	44
‘First week’ is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure	43
Abstract	43
Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study	42
Weight fluctuation and risk of hepatocellular carcinoma: a nationwide population-based 8-million-subject study	42
Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes	39
Diagnosis of significant liver fibrosis in patients with chronic hepatitis B using a deep learning-based data integration network	39
Evolution of risk prediction models for post-operative mortality in patients with cirrhosis	37
Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis	36
Is laparoscopic liver resection more suitable for diabetic patients with hepatocellular carcinoma? The debate continues	35
Obituary	34
Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status	33

Midodrine plus propranolol versus propranolol alone in preventing first bleed in patients with cirrhosis and severe ascites: a randomized controlled trial	31
Metabolic dysfunction-associated fatty liver disease and heavy alcohol consumption increase mortality:A nationwide study	31
PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study	30
Treating extrahepatic portal-vein obstruction with cavernoma using radiological interventions: pushing the boundaries	30
The safety profile of endoscopic variceal ligation in patients with esophageal varices	29
Predictive models for functional cure in patients with CHB receiving PEG-IFN therapy based on HBsAg quantification through meta-analysis	29
PIRO-CIC model can predict mortality and futility of care in critically ill cirrhosis patients in the intensive care unit	29
Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease	29